C4 Therapeutics Inc Working Capital to Net Assets Ratio
C4 Therapeutics Inc working capital to net assets ratio. C4 Therapeutics Inc (CCCC) has a Working Capital to Net Assets ratio of 86.8% as of June 2026. Working capital of $214.66 Million (current assets of $262.90 Million minus current liabilities of $48.25 Million) is measured against net assets of $247.26 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of C4 Therapeutics Inc (2018–2025)
Working capital to net assets ratio of C4 Therapeutics Inc from 2018 to 2025. This chart shows how C4 Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of June 2026, the ratio stands at 86.8%, reflecting working capital of $214.66 Million against net assets of $247.26 Million USD. Explore C4 Therapeutics Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
C4 Therapeutics Inc Working Capital to Net Assets Ratio by Year (2018–2025)
C4 Therapeutics Inc working capital to net assets ratio by year from 2018 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for C4 Therapeutics Inc from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see C4 Therapeutics Inc balance sheet assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 87.7% | $225.08 Million | $256.59 Million | $258.11 Million | $33.03 Million | ▼ -10.7 pp |
| 2024 | 98.4% | $212.59 Million | $215.99 Million | $257.77 Million | $45.18 Million | ▲ +5.6 pp |
| 2023 | 92.8% | $228.42 Million | $246.11 Million | $271.19 Million | $42.77 Million | ▲ +8.8 pp |
| 2022 | 84.0% | $243.01 Million | $289.23 Million | $287.56 Million | $44.55 Million | ▲ +13.6 pp |
| 2021 | 70.4% | $274.44 Million | $389.61 Million | $325.69 Million | $51.25 Million | ▼ -49.6 pp |
| 2020 | 120.1% | $337.16 Million | $280.79 Million | $381.01 Million | $43.85 Million | ▲ +176.5 pp |
| 2019 | -56.4% | $63.13 Million | $-111.96 Million | $96.77 Million | $33.64 Million | ▲ +68.5 pp |
| 2018 | -124.9% | $99.58 Million | $-79.75 Million | $123.53 Million | $23.95 Million | — |